Liver-Directed Treatments for Metastatic Colorectal Cancer

被引:0
作者
Michael A. Choti
机构
[1] University of Texas Southwestern Medical Center,Department of Surgery
来源
Current Treatment Options in Oncology | 2014年 / 15卷
关键词
Colorectal; Hepatic; Ablation; Hepatectomy; Liver embolization; Radioembolization;
D O I
暂无
中图分类号
学科分类号
摘要
When possible, surgical resection remains the “gold standard” for the treatment of hepatic colorectal metastases. Liver resection should be considered when complete removal of all macroscopic disease can be achieved safely. For those patients with unresectable metastases, or when a patient may not be a candidate for liver resection, many choices are available to the clinician in an attempt to achieve locoregional control, including tumor ablation, intra-arterial therapies, and radiation therapy. Whereas with surgical resection, durable local control can be considered potentially curable, other liver-directed approaches currently are mostly palliative. Ongoing trials are being undertaken to evaluate the role of such cytoreductive therapies. During the initial evaluation of any patient who might be a candidate for liver-directed therapy, particularly when the intent may be curative, complete assessment with high-quality imaging should be done before any therapy to determine the full extent of disease. Most importantly, the establishment of a multidisciplinary team upon initial diagnosis can optimize the choice and sequencing of the various systemic and locoregional choices available to the colorectal cancer patient.
引用
收藏
页码:456 / 464
页数:8
相关论文
共 205 条
  • [1] Tournigand C(2004)FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229-37
  • [2] Andre T(2005)Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 715-22
  • [3] Achille E(2004)Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases Ann Surg 239 818-25
  • [4] Pawlik TM(2006)Debunking dogma: surgery for four or more colorectal liver metastases is justified J Gastrointest Surg 10 240-8
  • [5] Scoggins CR(2007)Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group Eur J Cancer 43 2037-45
  • [6] Zorzi D(2010)Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 38-47
  • [7] Abdalla EK(2009)Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases Ann Surg Oncol 16 1202-7
  • [8] Vauthey J-N(2011)Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis J Gastrointest Surg 15 336-44
  • [9] Ellis LM(2008)Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases Ann Surg 248 994-1005
  • [10] Pawlik TM(2005)Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma Arch Surg 140 450-7